CI

At a glance

ClinicalIndex Comparison Record
N/ANot Yet Recruiting· 120 target
Drug / intervention
MB-1 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07363148
NCT07363148N/ANot Yet Recruiting
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

Arrae·interventional·Posted Jan 23, 2026·Updated Jun 30, 2026

In Brief

A clinical study evaluating MB-1 and Placebo for Obese and 4 related conditions. Not yet recruiting, targeting 120 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to investigate the safety and efficacy of MB-1 on metabolic health in overweight and obese adults. The main question it aims to answer is: What is the difference in change in body weight from baseline at Day 84 between MB-1 and placebo? Participants will be provided MB-1 or placebo and be assessed for anthropometric measurements, blood pressure, heart rate, and asked to complete appetite and satiety questionnaires and undergo a DEXA scan.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObese, Overweight Adults, Obese Adults, Body Weight Control, BMI
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ANot Yet Recruiting
20262027
First PostedJan 23, 2026
Enrollment StartAug 1, 2026
Primary CompletionJan 1, 2027
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 5 months agoPrimary completion in 6 months

Interventions

MB-1dietary

Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1 until the day prior to their end of study visit.

Placeboother

Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1 until the day prior to their end of study visit.